Dora E. Wiskirchen

592 total citations
20 papers, 501 citations indexed

About

Dora E. Wiskirchen is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Dora E. Wiskirchen has authored 20 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 8 papers in Molecular Medicine and 7 papers in Epidemiology. Recurrent topics in Dora E. Wiskirchen's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Antibiotic Resistance in Bacteria (8 papers) and Pneumonia and Respiratory Infections (5 papers). Dora E. Wiskirchen is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Antibiotic Resistance in Bacteria (8 papers) and Pneumonia and Respiratory Infections (5 papers). Dora E. Wiskirchen collaborates with scholars based in United States, France and Switzerland. Dora E. Wiskirchen's co-authors include David P. Nicolau, Joseph L. Kuti, Jared L. Crandon, S. Narasimha Murthy, Christopher Paul Bowers, Patrice Nordmann, Mao Hagihara, David P. Nicolau, Guilherme Henrique Campos Furtado and G. Williams and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Pharmaceutical Sciences.

In The Last Decade

Dora E. Wiskirchen

18 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dora E. Wiskirchen United States	12	286	239	165	111	94	20	501
Gladys Villas Boas do Prado Brazil	11	204 0.7×	304 1.3×	160 1.0×	125 1.1×	53 0.6×	16	550
Indran Balakrishnan United Kingdom	12	115 0.4×	206 0.9×	220 1.3×	84 0.8×	62 0.7×	23	456
Robin Haag Germany	4	158 0.6×	416 1.7×	104 0.6×	67 0.6×	108 1.1×	7	562
Jean Li Yan United States	13	238 0.8×	234 1.0×	226 1.4×	198 1.8×	58 0.6×	28	546
Nadia Castaldo Italy	13	194 0.7×	223 0.9×	160 1.0×	100 0.9×	44 0.5×	40	512
Tanaya Bhowmick United States	13	149 0.5×	104 0.4×	97 0.6×	111 1.0×	99 1.1×	33	381
Concepción Segura Spain	10	269 0.9×	442 1.8×	183 1.1×	41 0.4×	36 0.4×	12	556
G. Rahav Israel	5	115 0.4×	292 1.2×	114 0.7×	46 0.4×	75 0.8×	8	360
Nikolaos A. Triarides United States	8	182 0.6×	300 1.3×	215 1.3×	73 0.7×	38 0.4×	9	484
Patrick McLeroth United States	8	239 0.8×	331 1.4×	195 1.2×	93 0.8×	100 1.1×	12	554

Countries citing papers authored by Dora E. Wiskirchen

Since Specialization

Citations

This map shows the geographic impact of Dora E. Wiskirchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora E. Wiskirchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora E. Wiskirchen more than expected).

Fields of papers citing papers by Dora E. Wiskirchen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora E. Wiskirchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora E. Wiskirchen. The network helps show where Dora E. Wiskirchen may publish in the future.

Co-authorship network of co-authors of Dora E. Wiskirchen

This figure shows the co-authorship network connecting the top 25 collaborators of Dora E. Wiskirchen. A scholar is included among the top collaborators of Dora E. Wiskirchen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora E. Wiskirchen. Dora E. Wiskirchen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiskirchen, Dora E., et al.. (2024). Impact of stewardship pharmacist driven MRSA nasal surveillance and de-escalation of anti-MRSA therapy (STEW PHARM MRSA NASAL SURVEILLANCE). SHILAP Revista de lepidopterología. 4(1). e216–e216.

Wiskirchen, Dora E., et al.. (2021). 513. Use of Antimicrobial Stewardship Program in Operationalizing Monoclonal Antibody Therapy in SARS-CoV-2 Infection. Open Forum Infectious Diseases. 8(Supplement_1). S358–S358.

Wiskirchen, Dora E., et al.. (2018). Inpatient antibiotic resistance: Everyone's problem.. PubMed. 67(2). E1–E11. 3 indexed citations

Wiskirchen, Dora E., et al.. (2016). Antibiotic stewardship: The FP's role.. PubMed. 65(12). 876–885. 1 indexed citations

Ray, Amanda, et al.. (2015). Antibiotic Tissue Penetration in Diabetic Foot Infections. Journal of the American Podiatric Medical Association. 105(6). 520–531. 15 indexed citations

Wiskirchen, Dora E., Jared L. Crandon, & David P. Nicolau. (2013). Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 41(6). 582–585. 37 indexed citations

Wiskirchen, Dora E., Patrice Nordmann, Jared L. Crandon, & David P. Nicolau. (2013). Efficacy of Humanized Carbapenem and Ceftazidime Regimens against Enterobacteriaceae Producing OXA-48 Carbapenemase in a Murine Infection Model. Antimicrobial Agents and Chemotherapy. 58(3). 1678–1683. 41 indexed citations

Wiskirchen, Dora E., Patrice Nordmann, Jared L. Crandon, & David P. Nicolau. (2013). In VivoEfficacy of Human Simulated Regimens of Carbapenems and Comparator Agents against NDM-1-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 58(3). 1671–1677. 27 indexed citations

Wiskirchen, Dora E., Seth T. Housman, Richard Quintiliani, David P. Nicolau, & Joseph L. Kuti. (2013). Comparative Pharmacokinetics, Pharmacodynamics, and Tolerability of Ertapenem 1 Gram/Day Administered as a Rapid 5‐Minute Infusion versus the Standard 30‐Minute Infusion in Healthy Adult Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(3). 266–274. 31 indexed citations

10.

Wiskirchen, Dora E., Patrice Nordmann, Jared L. Crandon, & David P. Nicolau. (2013). Efficacy of Humanized Carbapenem Exposures against New Delhi Metallo-β-Lactamase (NDM-1)-Producing Enterobacteriaceae in a Murine Infection Model. Antimicrobial Agents and Chemotherapy. 57(8). 3936–3940. 29 indexed citations

11.

Suda, Katie J., et al.. (2012). Improving safe and appropriate use of antibiotics. Journal of the American Pharmacists Association. 52(1). 6–10. 4 indexed citations

12.

Furtado, Guilherme Henrique Campos, Dora E. Wiskirchen, Joseph L. Kuti, & David P. Nicolau. (2012). Performance of the PIRO Score for Predicting Mortality in Patients with Ventilator-Associated Pneumonia. Anaesthesia and Intensive Care. 40(2). 285–291. 8 indexed citations

13.

Wiskirchen, Dora E., Joseph L. Kuti, & David P. Nicolau. (2011). Acute Physiology and Chronic Health Evaluation II Score Is a Better Predictor of Mortality than IBMP-10 in Patients with Ventilator-Associated Pneumonia. Surgical Infections. 12(5). 385–390. 4 indexed citations

14.

Wiskirchen, Dora E., Jared L. Crandon, Guilherme Henrique Campos Furtado, G. Williams, & David P. Nicolau. (2011). In Vivo Efficacy of a Human-Simulated Regimen of Ceftaroline Combined with NXL104 against Extended-Spectrum-β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 55(7). 3220–3225. 50 indexed citations

15.

Wiskirchen, Dora E., Pornpan Koomanachai, Anthony M. Nicasio, David P. Nicolau, & Joseph L. Kuti. (2011). In Vitro Pharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination against Klebsiella pneumoniae Isolates Producing a KPC Carbapenemase. Antimicrobial Agents and Chemotherapy. 55(4). 1420–1427. 30 indexed citations

16.

Wiskirchen, Dora E., Joseph L. Kuti, & David P. Nicolau. (2011). The Use of Scoring Systems to Predict Prognosis in Patients With Ventilator-associated Pneumonia. Clinical Pulmonary Medicine. 18(4). 181–185. 3 indexed citations

17.

Hagihara, Mao, Dora E. Wiskirchen, Joseph L. Kuti, & David P. Nicolau. (2011). In Vitro Pharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 56(1). 202–207. 51 indexed citations

18.

Wiskirchen, Dora E., et al.. (2011). Determination of Tissue Penetration and Pharmacokinetics of Linezolid in Patients with Diabetic Foot Infections Using In Vivo Microdialysis. Antimicrobial Agents and Chemotherapy. 55(9). 4170–4175. 42 indexed citations

19.

Bulik, Catharine C., et al.. (2010). Tissue Penetration and Pharmacokinetics of Tigecycline in Diabetic Patients with Chronic Wound Infections Described by Using In Vivo Microdialysis. Antimicrobial Agents and Chemotherapy. 54(12). 5209–5213. 44 indexed citations

20.

Murthy, S. Narasimha, Dora E. Wiskirchen, & Christopher Paul Bowers. (2006). Iontophoretic Drug Delivery across Human Nail. Journal of Pharmaceutical Sciences. 96(2). 305–311. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact